400 related articles for article (PubMed ID: 25901298)
1. Selected mechanisms of molecular resistance of Candida albicans to azole drugs.
Gołąbek K; Strzelczyk JK; Owczarek A; Cuber P; Ślemp-Migiel A; Wiczkowski A
Acta Biochim Pol; 2015; 62(2):247-51. PubMed ID: 25901298
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
[TBL] [Abstract][Full Text] [Related]
3. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
4. Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans.
Xiang MJ; Liu JY; Ni PH; Wang S; Shi C; Wei B; Ni YX; Ge HL
FEMS Yeast Res; 2013 Jun; 13(4):386-93. PubMed ID: 23480635
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis.
Zhang MR; Zhao F; Wang S; Lv S; Mou Y; Yao CL; Zhou Y; Li FQ
BMC Infect Dis; 2020 Feb; 20(1):126. PubMed ID: 32046674
[TBL] [Abstract][Full Text] [Related]
6. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.
Coste A; Selmecki A; Forche A; Diogo D; Bougnoux ME; d'Enfert C; Berman J; Sanglard D
Eukaryot Cell; 2007 Oct; 6(10):1889-904. PubMed ID: 17693596
[TBL] [Abstract][Full Text] [Related]
7. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
8. ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates.
Xu Y; Sheng F; Zhao J; Chen L; Li C
Arch Microbiol; 2015 Nov; 197(9):1087-93. PubMed ID: 26349561
[TBL] [Abstract][Full Text] [Related]
9. Azole resistance in Candida albicans from animals: Highlights on efflux pump activity and gene overexpression.
Rocha MFG; Bandeira SP; de Alencar LP; Melo LM; Sales JA; Paiva MAN; Teixeira CEC; Castelo-Branco DSCM; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Brilhante RSN
Mycoses; 2017 Jul; 60(7):462-468. PubMed ID: 28295690
[TBL] [Abstract][Full Text] [Related]
10. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia.
Rosana Y; Yasmon A; Lestari DC
J Med Microbiol; 2015 Sep; 64(9):1046-1052. PubMed ID: 26297039
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
[TBL] [Abstract][Full Text] [Related]
13. Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene.
Feng LJ; Wan Z; Wang XH; Li RY; Liu W
Chin Med J (Engl); 2010 Mar; 123(5):544-8. PubMed ID: 20367978
[TBL] [Abstract][Full Text] [Related]
14. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles.
Chau AS; Mendrick CA; Sabatelli FJ; Loebenberg D; McNicholas PM
Antimicrob Agents Chemother; 2004 Jun; 48(6):2124-31. PubMed ID: 15155210
[TBL] [Abstract][Full Text] [Related]
15. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
Jensen RH; Astvad KM; Silva LV; Sanglard D; Jørgensen R; Nielsen KF; Mathiasen EG; Doroudian G; Perlin DS; Arendrup MC
J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
[TBL] [Abstract][Full Text] [Related]
17. Assessment of antifungal resistance and associated molecular mechanism in Candida albicans isolates from different cohorts of patients in North Indian state of Haryana.
Kumar A; Nair R; Kumar M; Banerjee A; Chakrabarti A; Rudramurthy SM; Bagga R; Gaur NA; Mondal AK; Prasad R
Folia Microbiol (Praha); 2020 Aug; 65(4):747-754. PubMed ID: 32219719
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of azole resistance mechanisms in Chilean clinical isolates of Candida albicans].
Fuentes M; Hermosilla G; Alburquenque C; Falconer MA; Amaro J; Tapia C
Rev Chilena Infectol; 2014 Oct; 31(5):511-7. PubMed ID: 25491448
[TBL] [Abstract][Full Text] [Related]
19. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
[TBL] [Abstract][Full Text] [Related]
20. Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors.
Schneider S; Morschhäuser J
Antimicrob Agents Chemother; 2015 Jan; 59(1):558-69. PubMed ID: 25385116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
